Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart Failure: Findings From the GWTG-HF Registry

Ítems similars

• Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the GWTG-HF Registry
  per: Khazanie, Prateeti, et al.
  Publicat: (2016)
• Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF
  per: Greene, Stephen J., et al.
  Publicat: (2019)
• Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure
  per: Gupta, Ankur, et al.
  Publicat: (2017)
• Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines–Heart Failure (GWTG-HF) Registry
  per: Vaduganathan, Muthiah, et al.
  Publicat: (2020)
• Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines–Heart Failure Registry
  per: Pandey, Ambarish, et al.
  Publicat: (2018)